Kristen Kluska
Stock Analyst at Cantor Fitzgerald
(4.78)
# 577
Out of 5,028 analysts
388
Total ratings
44.4%
Success rate
19.7%
Average return
Main Sectors:
Stocks Rated by Kristen Kluska
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| STO: EGTX Egetis Therapeutics AB (publ) | Reiterated: Buy | kr 23.00 → kr 33.00 | kr 9.06 | +264.24% | 2 | Sep 29, 2026 | |
| PTCT PTC Therapeutics | Rated: Buy | $130 → $137 | $63.65 | +115.24% | 26 | Sep 21, 2026 | |
| ABEO Abeona Therapeutics | Reiterated: Buy | $28 → $30 | $5.11 | +487.08% | 12 | Sep 17, 2026 | |
| MREO Mereo BioPharma Group | Reiterated: Buy | $3 | $0.388 | +673.20% | 11 | Sep 17, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $33 → $39 | $14.50 | +168.97% | 19 | Sep 17, 2026 | |
| SLDB Solid Biosciences | Reiterated: Buy | $26 | $7.06 | +268.27% | 4 | Sep 15, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $125 | $63.33 | +97.38% | 18 | Aug 31, 2026 | |
| CAPR Capricor Therapeutics | Upgraded: Buy | $3.5 → $28 | $7.78 | +259.90% | 16 | Aug 14, 2026 | |
| RNA Atrium Therapeutics | Reiterated: Buy | $25 | $7.97 | +213.68% | 2 | Aug 13, 2026 | |
| MNPR Monopar Therapeutics | Downgraded: Hold | $109 → $119 | $78.29 | +52.00% | 10 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $1.39 | +691.37% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27.07 | $10.99 | +146.33% | 11 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $4.49 | +323.16% | 20 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $32.59 | +87.17% | 27 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $7.14 | +124.09% | 10 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $30 → $12 | $10.11 | +18.69% | 13 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 | $17.49 | +20.07% | 28 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $25 | $10.70 | +133.64% | 10 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $38 → $43 | $47.79 | -10.02% | 14 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $10.51 | +356.71% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $67 | $42.76 | +56.69% | 10 | Jul 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $4.57 | +140.70% | 5 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $22.80 | - | 12 | Jun 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $3.41 | +457.18% | 5 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $24 | $3.71 | +546.90% | 8 | Mar 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 | $1.73 | +824.86% | 9 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $29 | $6.70 | +332.84% | 7 | Jan 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.90 | +382.76% | 8 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $7 | $0.50 | n/a | 4 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $4.38 | n/a | 6 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.9274 | n/a | 3 | Feb 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 → $20 | $0.5955 | n/a | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $14.89 | n/a | 3 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $1.20 | n/a | 3 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $20.22 | n/a | 1 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.41 | n/a | 2 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.5 → $28 | $0.10 | n/a | 2 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $20 | $0.0002 | n/a | 3 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 6 | Mar 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.25 → $10 | $1.12 | n/a | 3 | Dec 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $180 | $2.70 | n/a | 1 | Dec 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.04 | n/a | 6 | Sep 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $0.4601 | n/a | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $0.0005 | n/a | 1 | Mar 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $9 | $0.4038 | n/a | 1 | Nov 30, 2020 |
Egetis Therapeutics AB (publ)
Sep 29, 2026
Reiterated: Buy
Price Target: kr 23.00 → kr 33.00
Current: kr 9.06
Upside: +264.24%
PTC Therapeutics
Sep 21, 2026
Rated: Buy
Price Target: $130 → $137
Current: $63.65
Upside: +115.24%
Abeona Therapeutics
Sep 17, 2026
Reiterated: Buy
Price Target: $28 → $30
Current: $5.11
Upside: +487.08%
Mereo BioPharma Group
Sep 17, 2026
Reiterated: Buy
Price Target: $3
Current: $0.388
Upside: +673.20%
Ultragenyx Pharmaceutical
Sep 17, 2026
Reiterated: Buy
Price Target: $33 → $39
Current: $14.50
Upside: +168.97%
Solid Biosciences
Sep 15, 2026
Reiterated: Buy
Price Target: $26
Current: $7.06
Upside: +268.27%
Disc Medicine
Aug 31, 2026
Reiterated: Buy
Price Target: $125
Current: $63.33
Upside: +97.38%
Capricor Therapeutics
Aug 14, 2026
Upgraded: Buy
Price Target: $3.5 → $28
Current: $7.78
Upside: +259.90%
Atrium Therapeutics
Aug 13, 2026
Reiterated: Buy
Price Target: $25
Current: $7.97
Upside: +213.68%
Monopar Therapeutics
Aug 12, 2026
Downgraded: Hold
Price Target: $109 → $119
Current: $78.29
Upside: +52.00%
Aug 11, 2026
Reiterated: Buy
Price Target: $11
Current: $1.39
Upside: +691.37%
Aug 11, 2026
Reiterated: Buy
Price Target: $27.07
Current: $10.99
Upside: +146.33%
Aug 11, 2026
Reiterated: Buy
Price Target: $19
Current: $4.49
Upside: +323.16%
Aug 6, 2026
Reiterated: Buy
Price Target: $61
Current: $32.59
Upside: +87.17%
Aug 6, 2026
Reiterated: Buy
Price Target: $16
Current: $7.14
Upside: +124.09%
Aug 5, 2026
Reiterated: Hold
Price Target: $30 → $12
Current: $10.11
Upside: +18.69%
Aug 5, 2026
Reiterated: Hold
Price Target: $21
Current: $17.49
Upside: +20.07%
Aug 5, 2026
Reiterated: Buy
Price Target: $34 → $25
Current: $10.70
Upside: +133.64%
Aug 4, 2026
Reiterated: Hold
Price Target: $38 → $43
Current: $47.79
Upside: -10.02%
Jul 16, 2026
Reiterated: Buy
Price Target: $48
Current: $10.51
Upside: +356.71%
Jul 9, 2026
Reiterated: Buy
Price Target: $63 → $67
Current: $42.76
Upside: +56.69%
Jun 25, 2026
Reiterated: Buy
Price Target: $11
Current: $4.57
Upside: +140.70%
Jun 17, 2026
Upgraded: Buy
Price Target: n/a
Current: $22.80
Upside: -
Mar 30, 2026
Reiterated: Buy
Price Target: $19
Current: $3.41
Upside: +457.18%
Mar 19, 2026
Reiterated: Buy
Price Target: $15 → $24
Current: $3.71
Upside: +546.90%
Mar 10, 2026
Reiterated: Hold
Price Target: $16
Current: $1.73
Upside: +824.86%
Jan 13, 2026
Reiterated: Buy
Price Target: $29
Current: $6.70
Upside: +332.84%
Nov 21, 2025
Reiterated: Buy
Price Target: $14
Current: $2.90
Upside: +382.76%
Jul 1, 2024
Reiterated: Buy
Price Target: $6 → $7
Current: $0.50
Upside: n/a
May 13, 2024
Rated: Buy
Price Target: n/a
Current: $4.38
Upside: n/a
Feb 4, 2024
Reiterated: Buy
Price Target: $6
Current: $0.9274
Upside: n/a
Aug 30, 2023
Downgraded: Hold
Price Target: $4 → $20
Current: $0.5955
Upside: n/a
Aug 28, 2023
Reiterated: Buy
Price Target: $23
Current: $14.89
Upside: n/a
Jun 28, 2023
Reiterated: Buy
Price Target: $27
Current: $1.20
Upside: n/a
Jun 26, 2023
Reiterated: Buy
Price Target: $17
Current: $20.22
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.41
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $3.5 → $28
Current: $0.10
Upside: n/a
Mar 16, 2023
Downgraded: Hold
Price Target: $28 → $20
Current: $0.0002
Upside: n/a
Mar 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Dec 21, 2022
Reiterated: Hold
Price Target: $4.25 → $10
Current: $1.12
Upside: n/a
Dec 29, 2021
Initiated Coverage: Buy
Price Target: $180
Current: $2.70
Upside: n/a
Sep 28, 2021
Reiterated: Hold
Price Target: $4
Current: $1.04
Upside: n/a
May 12, 2021
Reiterated: Buy
Price Target: $10
Current: $0.4601
Upside: n/a
Mar 2, 2021
Initiated Coverage: Buy
Price Target: $22
Current: $0.0005
Upside: n/a
Nov 30, 2020
Initiated Coverage: Buy
Price Target: $9
Current: $0.4038
Upside: n/a